Case Details
- Citation: [2021] SGCA 111
- Title: Noor Azlin bte Abdul Rahman & Anor v Changi General Hospital Pte Ltd
- Court: Court of Appeal of the Republic of Singapore
- Date of Decision: 29 November 2021
- Court File / Appeal No: Civil Appeal No 39 of 2021
- Related Suit: Suit No 59 of 2015
- Proceedings Context: Sequel to the Court of Appeal’s earlier decision in the “first CA Judgment” (Noor Azlin bte Abdul Rahman v Changi General Hospital Pte Ltd and others [2019] 1 SLR 834)
- Judges: Andrew Phang Boon Leong JCA and Judith Prakash JCA
- Appellants / Plaintiffs: (1) Noor Azlin bte Abdul Rahman; (2) Azmi Bin Abdul Rahman (executor of Ms Azlin’s estate)
- Respondent / Defendant: Changi General Hospital Pte Ltd
- Other Defendants in Suit (not central to CA/CA 39): Imran Bin Mohamed Noor; Yap Hsiang; Soh Wei Wen, Jason
- Legal Area: Tort (medical negligence) — damages assessment and quantification
- Key Topics in Judgment: Damages — assessment/quantum; life expectancy; pain and suffering; loss of amenity; loss of marriage prospects; post-writ expenses; loss of earnings and CPF contributions; aggravated and punitive damages; costs for AD hearing
- Statutes Referenced: Companies Act; Supreme Court of Judicature Act
- Length: 120 pages; 36,537 words
- Prior/Related Decisions Cited (as per metadata): [2016] SGHC 46; [2020] SGCA 8; [2020] SGHC 260; [2021] SGCA 92; [2021] SGCA 111; [2021] SGHC 10
Summary
This Court of Appeal decision, [2021] SGCA 111, concerns the quantification of damages following a finding of medical negligence against Changi General Hospital Pte Ltd (“CGH”). The appeal (CA/CA 39/2021) was a sequel to the Court of Appeal’s earlier “first CA Judgment” in which CGH was held to be in breach of its duty of care to Ms Noor Azlin bte Abdul Rahman (“Ms Azlin”). That earlier decision found that CGH’s negligence caused a delay in diagnosing Ms Azlin’s lung cancer, with the consequence that the cancer progressed from stage I to stage IIA, including growth of the cancerous nodule and subsequent metastasis.
In the present appeal, liability and causation were not in issue. The only matters were the High Court judge’s (“the Judge”) assessment of damages and costs after a six-day trial on loss and damage. A crucial factual development occurred shortly after the first Court of Appeal decision: Ms Azlin died from cancer about a month after the first CA Judgment. Her brother, Mr Azmi, was added as executor to continue the action. The Court of Appeal emphasised that this death “fundamentally altered” the evidential and pleading landscape, and that the appellants’ approach to the case—particularly the way heads of claim were pleaded and proved—limited the damages that could be awarded.
The Court of Appeal allowed the appeal in part. It increased the damages awarded by the Judge from $326,620.61 to $343,020.61 (excluding the costs of the AD hearing, which were affirmed at $105,000). The Court affirmed the Judge’s costs order for the AD hearing and provided a detailed breakdown of the revised quantum across multiple heads of damages.
What Were the Facts of This Case?
The dispute began in 2015 when Ms Azlin sued CGH in relation to medical treatment she received at CGH’s Accident and Emergency (“A&E”) department on 31 October 2007. The litigation was long and acrimonious, and the case has returned to the appellate courts multiple times. While the present judgment focuses on damages quantification, it is anchored in the earlier appellate finding that CGH’s negligence delayed diagnosis of Ms Azlin’s lung cancer.
In the first CA Judgment, the Court of Appeal held that CGH breached its duty of care and that the negligence caused the cancer to progress. The Court remitted the question of loss and damage, including whether damages should be awarded and, if so, the quantum, to the High Court judge for determination. This remittal was expressly made with leave for the parties to refine or revise their evidence, recognising that quantification would depend on the evidential record and the pleaded heads of claim.
After the first CA Judgment was released, Ms Azlin died from cancer. The Court of Appeal described this as a tragic turn of events that altered the factual and evidential matrix. The action continued through her brother, Mr Azmi, who was added as a party in his capacity as executor of Ms Azlin’s estate. Importantly, the Court noted that Mr Azmi did not pursue separate causes of action in his own right; he continued the estate’s claim.
At the High Court trial on loss and damage (the “AD Hearing”), the Judge assessed causation and then quantified damages. The Court of Appeal in the present case accepted that the Judge found a causal link between CGH’s negligence and Ms Azlin’s death. However, the Court of Appeal’s review of quantum revealed that many claims were not properly pleaded or supported by sufficient evidence, especially in light of Ms Azlin’s death and the consequent need to align the pleaded heads of claim with what could be recovered by an estate (or dependants) rather than by a living claimant.
What Were the Key Legal Issues?
The central legal issues in CA/CA 39/2021 were not about whether CGH was liable, but about how damages should be quantified once liability and causation were established. Specifically, the Court had to determine whether the Judge’s awards across various heads of damages were correct in law and in principle, and whether the evidence and pleadings supported the claimed losses.
Several discrete issues were addressed. These included: (1) life expectancy as it affects damages for pain and suffering and related heads; (2) pain and suffering, loss of amenity, and loss of marriage prospects; (3) the recoverability and proof of post-writ expenses (including medical, transport, and nursing/domestic/auxiliary helper costs); (4) loss of earnings and CPF contributions (distinguishing between “living years” and “lost years”); and (5) whether aggravated and punitive damages could be awarded given the pleading and procedural posture. The Court also dealt with costs for the AD hearing.
Underlying these issues was a more fundamental procedural and evidential question: to what extent can a court award damages for heads of loss that were not properly pleaded and/or not supported by the requisite evidence, particularly after the claimant’s death changed the nature of recoverable losses.
How Did the Court Analyse the Issues?
The Court of Appeal began by framing the appeal as a “sequel” to the first CA Judgment and by stressing the limits of appellate review in a damages quantification context. It reiterated that no challenge was brought against the Judge’s decision on causation and liability. Accordingly, the Court’s task was confined to the quantification of damages and costs.
However, the Court’s analysis was heavily influenced by pleading and proof deficiencies. The Court observed that the appellants’ case was advanced on the basis that Ms Azlin was alive, despite her death. The Court characterised this as a “fundamental” misalignment: the appellants did not seek leave to amend pleadings to reflect heads of claim consonant with death (notably, a claim for loss of inheritance). Further, despite the first CA Judgment’s express order remitting loss and damage with leave to refine or revise evidence, the appellants confirmed they would not need to call witnesses to give evidence on quantification during the AD Hearing. The Court treated these choices as consequential: they limited what could be proved and therefore compensated.
In discussing the general approach to tortious damages, the Court reiterated that damages are adjudicated on the basis of pleaded claims and evidence adduced. It emphasised that, in almost all instances, the burden of proof lies on the party seeking to vindicate the claim. The Court acknowledged the enormity of the loss and suffering, but maintained that the court is bound by the evidential and pleading framework before it. This approach is consistent with the broader principle that damages are not awarded in the abstract; they must be supported by the pleadings and proof.
On Issue 1: life expectancy, the Court examined how life expectancy should be treated in quantifying damages for pain and suffering and related components. The Court accepted that awareness of reduced life expectancy can be relevant to pain and suffering awards. It scrutinised the Judge’s approach and the evidence supporting the claimant’s awareness and the extent to which that awareness affected the claimant’s suffering. The Court’s final award maintained the Judge’s quantum for the relevant component (pain and suffering from awareness of reduction in life expectancy), reflecting that the evidential basis and the pleaded structure supported that head.
On Issue 2: pain and suffering, loss of amenity and loss of marriage prospects, the Court analysed the general law on pain and suffering and how it should be decomposed into components. It also considered loss of amenity (excluding loss of marriage prospects) and loss of marriage prospects as distinct heads. The Court’s reasoning reflected the need to avoid double counting and to ensure that each head corresponds to a legally recognised category of loss. The Court affirmed the Judge’s approach in most respects but adjusted the quantum for loss of marriage prospects, awarding $6,000 where the Judge had awarded none. This indicates that while many claims failed due to pleading/evidence gaps, some components were sufficiently supported to warrant modification.
On Issue 3: Ms Azlin’s expenses from 2014 to 1 April 2019 (post-writ), the Court focused on recoverability and proof. It distinguished between post-writ medical expenses, transport expenses, and expenses for nursing care, domestic and auxiliary helper. The Court’s approach was evidence-driven: where the appellants did not adduce sufficient evidence that expenses were incurred up to the relevant time (including up to death), the court could not award those sums. The Court ultimately allowed transport expenses for the post-writ period (awarding $10,400) while rejecting other categories, consistent with the evidential record.
On Issue 4: loss of earnings and CPF contributions, the Court again emphasised the interplay between death, pleading, and proof. The Court distinguished between “living years” (2016 to 2018) and “lost years” (2019 to 2044). The Judge had awarded nothing for these heads, and the Court upheld that position. The Court’s reasoning reflects that, after death, claims for future earnings and CPF contributions must be carefully pleaded and supported by evidence. Where the appellants’ case was advanced as if the claimant were alive, the evidential and pleading foundation for these heads was undermined.
On Issue 5: aggravated and punitive damages, the Court addressed a procedural and substantive threshold. Aggravated and punitive damages are exceptional. The Court examined the “general rules on pleadings” and the exceptional nature of such damages, including the purpose and object of pleadings: to give fair notice of the case to be met. The Court found that aggravated or punitive damages were not properly pleaded and/or supported, and therefore could not be awarded. This part of the judgment underscores that even where liability is established, exceptional damages require strict compliance with pleading requirements and a proper evidential basis.
Finally, on Issue 6: costs for the AD hearing, the Court affirmed the Judge’s award of $105,000. This indicates that, while the Court modified damages quantum, it did not disturb the costs assessment for the trial on loss and damage.
What Was the Outcome?
The Court of Appeal allowed CA 39 in part. It increased the damages awarded from $326,620.61 to $343,020.61. The Court affirmed the Judge’s costs award of $105,000 for the AD hearing.
In practical terms, the Court’s revised award maintained the Judge’s major components for pain and suffering and related heads, rejected several expense and earnings/CPF claims due to pleading and proof deficiencies, and made a limited adjustment by awarding $6,000 for loss of marriage prospects and $10,400 for post-writ transport expenses. The Court’s final structure reflects a careful recalibration of what was legally recoverable and evidentially supported.
Why Does This Case Matter?
This case is significant for practitioners because it demonstrates how damages quantification in tort is constrained by pleading discipline and evidential sufficiency. Even where liability and causation are established, a claimant’s recovery can be materially limited if heads of loss are not properly pleaded or if the evidence does not support the claimed losses—especially after a major factual change such as the claimant’s death.
From a procedural standpoint, the decision reinforces the exceptional nature of aggravated and punitive damages and the importance of fair notice through pleadings. The Court’s analysis of the purpose of pleadings and the need for strict compliance is a reminder that courts will not award exceptional damages merely because the facts suggest wrongdoing; the legal basis must be properly raised and proved.
For medical negligence litigation, the case also highlights the evidential challenges in proving post-writ expenses and future losses. Practitioners should take from this judgment the need to align pleadings with the claimant’s status (alive versus deceased) and to ensure that quantification evidence is properly marshalled, including witness evidence where necessary. The Court’s observation that the appellants confirmed they would not call witnesses on quantification, despite an express remittal with leave to refine evidence, illustrates the risk of procedural strategy undermining substantive recovery.
Legislation Referenced
- Companies Act
- Supreme Court of Judicature Act
Cases Cited
- [2016] SGHC 46
- [2020] SGCA 8
- [2020] SGHC 260
- [2021] SGCA 92
- [2021] SGCA 111
- [2021] SGHC 10
Source Documents
This article analyses [2021] SGCA 111 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.